Radiation oncology firm Elekta posted a 3% decline in revenue after currency adjustment for its third quarter, which it attributed to supply chain challenges.
The company posted revenue of 3.6 billion Swedish krona ($382.8 million U.S.), a 3% decrease compared with the same period last year.
The company did see an 8% increase in orders compared to last year's third quarter, taking orders worth 4.4 billion krona ($468 million). The company is seeing a spike in orders from Europe, Egypt, and India, it said.
![A 53-year-old patient (patient number four) with a recurrent pituitary adenoma with extension of a cystic component of disease to the medial temporal lobe apparent on MRI (contoured in blue), and extension of disease to the left sphenoid bone and orbital apex apparent on [68Ga]Ga-DOTA-TATE (contoured in yellow).](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/04/pituitary-tumor.QGsEnyB4bU.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
